Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06152094 · ClinicalTrials.gov registry record · NA
UCSF BP Activate Letter Study
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 484
- Enrollment target
NCT06152094 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 484 participants.
The verdict
NCT06152094, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 484 participants
- Enrollment target
Study Summary
The BP Activate Study aims to assess the effectiveness of the BP Report letter with personalized BP medication recommendations, compared with Control letters and no intervention, at shortening time to appointment, time to visit, time to medication change, and time to achievement of BP goal.
Interventions
- OTHER BP Activate Letter
- OTHER Control Letter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 484 participants |
| Start Date | 2023-07-20 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06152094
The ClinicalTrials.gov registry entry for NCT06152094 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 484 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BP Activate Letter is the first listed.
NCT06152094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06152094 about?
NCT06152094 is a clinical study titled "UCSF BP Activate Letter Study". The BP Activate Study aims to assess the effectiveness of the BP Report letter with personalized BP medication recommendations, compared with Control letters and no intervention, at shortening time to appointment, time to visit, time to medication change, and time to achievement of BP goal.
What is the current status of trial NCT06152094?
This trial is currently completed. It is a NA study. The enrollment target is 484 participants. The study started on 2023-07-20. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06152094?
The interventions under investigation include: BP Activate Letter (OTHER), Control Letter (OTHER).
Who is sponsoring clinical trial NCT06152094?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.